StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
14
Publishing Date
2023 - 12 - 12
1
2023 - 10 - 24
1
2023 - 10 - 04
1
2023 - 06 - 30
1
2023 - 02 - 10
1
2022 - 08 - 15
1
2022 - 03 - 15
1
2021 - 10 - 26
1
2021 - 07 - 08
1
2021 - 06 - 30
1
2021 - 06 - 16
1
2021 - 04 - 20
1
2021 - 02 - 17
1
2020 - 12 - 28
1
Sector
Communications
1
Consumer durables
1
Finance
1
Health technology
14
Manufacturing
2
Tags
100
1
Application
1
Authorization
1
Biotechnology
1
Brazil
1
Business
1
Cancer
1
Candidiasis
1
Children
1
Cibinqo
1
Collaboration
1
Covid
4
Covid-19
1
Disease
1
Drug
1
Duchenne
1
Emergency use authorization
2
Expansion
1
Fda
3
Fda-approvals
1
Genetic
1
Global
3
Growing
1
In vitro
1
Index
1
License
1
Life
1
Lung cancer
1
Market
2
Merge
2
N/a
10
Order
1
Pharm-country
1
Positive
1
Rare
1
Report
2
Research
2
Results
1
Sars-cov-2
1
Therapeutics
1
Tiona
1
Treatment
1
Vaccine
4
Entities
Abbvie inc.
2
Alkermes plc
1
Astellas pharma inc
1
Astrazeneca plc
1
Biogen inc.
1
Biontech se
3
Bristol-myers squibb company
2
Cidara therapeutics, inc.
1
Eli lilly and company
2
Glaxosmithkline plc
1
Johnson & johnson
1
Lexicon pharmaceuticals, inc.
1
Nasdaq, inc.
1
Neurocrine biosciences, inc.
1
Novartis ag
1
Orange
1
Pfizer, inc.
14
Ptc therapeutics, inc.
1
Sanofi
4
Scynexis, inc.
1
Seagen inc.
1
Spero therapeutics, inc.
1
Take-two interactive software, inc.
1
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries ltd
1
Ucb s.a.
1
Symbols
AAPL
60
ABB
56
ABBNY
35
ABBV
45
ABLZF
47
ABT
75
ACAQ
38
ACN
31
ADBE
30
AMGN
44
ARVL
156
AVGO
29
AZN
27
BRO
29
CNS
76
CSCO
30
DELL
42
DHR
34
ERIC
38
FNCTF
211
FRBA
29
FST
33
GE
32
GOOG
63
GOOGL
63
GSK
32
HON
100
HUBS
104
INTC
28
JNJ
120
KGS
30
LLY
52
LTUM
28
MDT
42
MMM
35
MS
183
MSFT
50
NBR
36
NOC
37
NVS
44
NVSEF
40
OOMA
42
ORCL
38
PB
35
PCRFF
29
PCRFY
29
PHG
37
PPRUF
31
PPRUY
31
SAP
62
SAPGF
56
SNOW
39
SNY
117
SNYNF
102
SPGI
65
TEVJF
34
TMO
73
TRU
33
VZ
29
XYF
33
Exchanges
Nasdaq
10
Nyse
14
Crawled Date
2023 - 12 - 12
1
2023 - 10 - 24
1
2023 - 10 - 04
1
2023 - 06 - 30
1
2023 - 02 - 10
1
2022 - 08 - 15
1
2022 - 03 - 15
1
2021 - 10 - 26
1
2021 - 07 - 08
1
2021 - 06 - 30
1
2021 - 06 - 16
1
2021 - 04 - 20
1
2021 - 02 - 17
1
2020 - 12 - 28
1
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
38
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
www.biospace.com
4
www.globenewswire.com
6
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Pfe
crawled time :
23:00
save search
Update: Annual Changes to the Nasdaq-100® Index
Published:
2023-12-12
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-11.06%
|
O:
-8.05%
H:
1.71%
C:
1.45%
TTWO
4
|
$140.64
-1.76%
-1.79%
1.5M
|
Consumer Durables
|
-8.93%
|
O:
2.51%
H:
1.8%
C:
1.23%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
-0.05%
|
O:
0.03%
H:
0.01%
C:
-0.08%
NDAQ
|
$60.075
0.11%
0.11%
2.3M
|
Finance
|
10.78%
|
O:
0.11%
H:
4.08%
C:
3.98%
100
index
Rising R&D Investment and Government Support Fuel Expansion of Global Duchenne Muscular Dystrophy Drugs Market
Published:
2023-10-24
(Crawled : 23:00)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-16.46%
|
O:
0.1%
H:
1.77%
C:
0.89%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
29.23%
|
O:
2.75%
H:
0.46%
C:
-1.76%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-13.93%
|
O:
-0.18%
H:
1.34%
C:
1.05%
PTCT
|
$24.71
-1.79%
-1.82%
820K
|
Health Technology
|
8.35%
|
O:
-1.34%
H:
2.23%
C:
1.62%
LXRX
|
News
|
$1.625
0.31%
0.31%
3.7M
|
Health Technology
|
39.08%
|
O:
-1.68%
H:
0.85%
C:
-2.99%
expansion
global
duchenne
market
Global Vulvovaginal Candidiasis Treatment Market Research Report 2023-2028 - Demand for Cost-effective Vulvovaginal Candidiasis Treatment Soars with Growing Geriatric Population
Published:
2023-10-04
(Crawled : 23:00)
- prnewswire.com
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-30.87%
|
O:
0.59%
H:
0.29%
C:
0.22%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-23.69%
|
O:
0.42%
H:
0.99%
C:
0.06%
SCYX
|
$1.47
3.52%
3.4%
80K
|
Health Technology
|
-36.04%
|
O:
0.45%
H:
4.04%
C:
0.45%
CDTX
|
$0.7201
-0.29%
-0.29%
270K
|
Health Technology
|
-22.58%
|
O:
0.39%
H:
10.33%
C:
3.9%
report
treatment
candidiasis
research
global
growing
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.78
-0.96%
-0.97%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.49
-0.56%
-0.56%
550K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$64.07
-4.38%
72K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$140.15
-4.19%
560
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.36
-0.25%
-0.25%
4M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
Published:
2023-02-10
(Crawled : 23:00)
- biospace.com/
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-41.35%
|
O:
0.37%
H:
1.1%
C:
0.87%
cibinqo
fda
drug
application
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
Published:
2022-08-15
(Crawled : 23:00)
- biospace.com/
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-49.27%
|
O:
-0.28%
H:
0.19%
C:
-0.44%
results
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published:
2022-03-15
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-51.31%
|
O:
0.56%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-11.53%
|
O:
0.82%
H:
0.0%
C:
0.0%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-40.59%
|
O:
1.63%
H:
11.55%
C:
11.21%
covid-19
covid
authorization
vaccine
tiona
merge
order
emergency use authorization
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published:
2021-10-26
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-41.28%
|
O:
0.39%
H:
0.23%
C:
-1.13%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-8.32%
|
O:
0.91%
H:
0.06%
C:
-1.04%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-70.86%
|
O:
-0.4%
H:
1.16%
C:
-5.35%
covid
fda
children
vaccine
merge
emergency use authorization
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
Published:
2021-07-08
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-35.24%
|
O:
0.71%
H:
1.44%
C:
0.2%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
41.95%
|
O:
-0.04%
H:
0.88%
C:
0.24%
BIIB
|
$190.55
-0.84%
-0.84%
1.5M
|
Health Technology
|
-47.12%
|
O:
0.83%
H:
0.0%
C:
0.0%
disease
genetic
collaboration
rare
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206
Published:
2021-06-30
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-35.09%
|
O:
0.03%
H:
1.17%
C:
1.0%
SPRO
|
$1.48
-1.33%
-1.35%
240K
|
Health Technology
|
-89.26%
|
O:
19.27%
H:
2.94%
C:
-1.56%
license
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia
Published:
2021-06-16
(Crawled : 23:00)
- biospace.com/
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-35.79%
|
O:
0.08%
H:
0.56%
C:
-0.81%
covid
brazil
Insights on the Meningococcal Vaccine Global Market to 2026 - Featuring GlaxoSmithKline, Pfizer and Sanofi Among Others
Published:
2021-04-20
(Crawled : 23:00)
- prnewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-34.87%
|
O:
0.28%
H:
1.35%
C:
1.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
5.04%
|
O:
0.72%
H:
0.93%
C:
0.74%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-12.48%
|
O:
0.48%
H:
0.59%
C:
0.4%
vaccine
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
Published:
2021-02-17
(Crawled : 23:00)
- globenewswire.com
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-27.14%
|
O:
-0.32%
H:
0.28%
C:
-0.63%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-24.12%
|
O:
-4.9%
H:
5.19%
C:
4.31%
covid
vaccine
sars-cov-2
in vitro
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA
Published:
2020-12-28
(Crawled : 23:00)
- biospace.com/
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-31.8%
|
O:
0.24%
H:
0.59%
C:
-1.45%
positive
cancer
fda
lung cancer
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.